text_combined: eleanor blume eblumealumwellesleyedu picked textplain multipartalternative httponlinewsjcompublicarticlesb121746894789699503htmlmod2_1566_leftbox generics fuel aids program sarah lueck july 31 2008 page b5 washington companies make generic drugs many based india dominate president george w bushs program provide aids treatment poor countries generic drugs copies combinations brandname products accounted 57 131 million us spent program fiscal 2007 according office us global aids coordinator 2005 generics accounted 11 programs funding time us approved generics antiaids initiative money went buy brandname drugs often expensive aurobindo pharma ltd genericdrug maker india biggest player fiscal 2007 ended sept 30 presidents emergency plan aids relief pepfar spent 39 million aurobindo pharma products fight hiv aids indias cipla ltd received 15 million ranbaxy laboratories also india received nearly 9 million south africas aspen pharmacare holdingsltd received nearly 13 million pepfar sells generic aids drugs countries produces brandname products partnership gilead sciences inc foster city calif pepfars shift generics past two years followed bush administration decision set special approval food drug administration drugs marketed us patent exclusivity laws protect brandname versions pepfar provides treatment patients 15 poor countries mostly subsaharan africa bush officials came fire program began five years ago activists generics industry complained requirement fda approval skewed purchases toward moreexpensive brandname products meaning fewer people would treated wednesday mr bush signed 48 billion fiveyear expansion program draws widespread praise viewed major part legacy congress must appropriate funds also go toward treatment prevention malaria tuberculosis pretty clear system working well protects african families like american families protected said ambassador mark dybul us global aids coordinator pretty methodically said going pepfars spending brandname drugs totaled 56 million fiscal year 2007 106 million 2005 merck co appeared biggest recipient funds 2007 nearly 16 million going whitehouse station njbased company glaxosmithklineplc uk received 12 million pepfar including licensing agreements makers generics abbott laboratoriesof abbott park ill received nearly 9 million 2007 generics companies pleased changes past two years earlier work well none products approved said yusuf hamied ciplas chairman managing director competition money put better use said funds cipla receives pepfar arent significant business perspective company participates humanitarian reasons helped build pressure brandnamedrug companies lower prices poor countries key affordable accessible medicines think generic industry made contribution positive way pepfar said chuck caprariello ranbaxy spokesman write sarah lueck sarahlueckwsjcom _______________________________________________ iphealth mailing list iphealthlistsessentialorg httplistsessentialorgmailmanlistinfoiphealth tue 05 aug 2008 145938 0530 iphealth wsj generics fuel aids program